Neogen Total Liabilities and Share Holders Equity 2010-2025 | NEOG
Neogen total liabilities and share holders equity from 2010 to 2025. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
Neogen Annual Total Liabilities and Share Holders Equity (Millions of US $) |
2024 |
$4,549 |
2023 |
$4,554 |
2022 |
$993 |
2021 |
$920 |
2020 |
$797 |
2019 |
$696 |
2018 |
$618 |
2017 |
$528 |
2016 |
$450 |
2015 |
$392 |
2014 |
$345 |
2013 |
$291 |
2012 |
$252 |
2011 |
$220 |
2010 |
$180 |
2009 |
$142 |
Neogen Quarterly Total Liabilities and Share Holders Equity (Millions of US $) |
2025-02-28 |
$4,036 |
2024-11-30 |
$4,054 |
2024-08-31 |
$4,503 |
2024-05-31 |
$4,549 |
2024-02-29 |
$4,582 |
2023-11-30 |
$4,602 |
2023-08-31 |
$4,561 |
2023-05-31 |
$4,554 |
2023-02-28 |
$4,509 |
2022-11-30 |
$4,563 |
2022-08-31 |
$977 |
2022-05-31 |
$993 |
2022-02-28 |
$981 |
2021-11-30 |
$968 |
2021-08-31 |
$932 |
2021-05-31 |
$920 |
2021-02-28 |
$880 |
2020-11-30 |
$846 |
2020-08-31 |
$822 |
2020-05-31 |
$797 |
2020-02-29 |
$774 |
2019-11-30 |
$751 |
2019-08-31 |
$721 |
2019-05-31 |
$696 |
2019-02-28 |
$673 |
2018-11-30 |
$660 |
2018-08-31 |
$641 |
2018-05-31 |
$618 |
2018-02-28 |
$596 |
2017-11-30 |
$581 |
2017-08-31 |
$547 |
2017-05-31 |
$528 |
2017-02-28 |
$507 |
2016-11-30 |
$487 |
2016-08-31 |
$469 |
2016-05-31 |
$450 |
2016-02-29 |
$432 |
2015-11-30 |
$426 |
2015-08-31 |
$409 |
2015-05-31 |
$392 |
2015-02-28 |
$378 |
2014-11-30 |
$366 |
2014-08-31 |
$358 |
2014-05-31 |
$345 |
2014-02-28 |
$330 |
2013-11-30 |
$320 |
2013-08-31 |
$308 |
2013-05-31 |
$291 |
2013-02-28 |
$281 |
2012-11-30 |
$270 |
2012-08-31 |
$261 |
2012-05-31 |
$252 |
2012-02-29 |
$240 |
2011-11-30 |
$234 |
2011-08-31 |
$228 |
2011-05-31 |
$220 |
2011-02-28 |
$209 |
2010-11-30 |
$204 |
2010-08-31 |
$191 |
2010-05-31 |
$180 |
2010-02-28 |
$165 |
2009-11-30 |
$161 |
2009-08-31 |
$152 |
2009-05-31 |
$142 |
2009-02-28 |
$140 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED PRODUCTS |
$1.248B |
$0.924B |
Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada.
|